Skip to main content
Union for International Cancer Control
Search this site
Secondary menu
Home
About UICC
Press lounge
Resources
Donate
Partners
Main menu
Home
Declaration
Membership
Programmes
Events
Ambassadors
Advocacy
Fellowships
Community
You are here:
Home
Text Size
Current Size:
100%
CME Regional Symposium, "Current Role of EGFR Tyrosine Kinase Inhibitors in NSCLC: Which Patients and Why"
Fri, 10/12/2004
-
Sat, 05/03/2005
Address of event:
1707 Market Place Blvd., Ste. 370
United States
TX
Irving
75063
Event language:
English
UICC Member:
No
Organiser:
The Center for Biomedical Continuing Education, supported by an educational grant from Genentech, Inc.
Contact name:
Megan Ollinger
Email:
info@thecbce.com
Phone:
260 9024
Website:
http://www.thecbce.com
Topics:
Oncology
Other topic:
EGFR
Under the auspices of UICC:
No
NCI Event:
No
Related Content
CME Regional Symposium, "Current Role of EGFR Tyrosine Kinase Inhibitors in NSCLC: Which Patients and Why"
CME Regional Symposium, "Current Role of EGFR Tyrosine Kinase Inhibitors in NSCLC: Which Patients and Why"
Translational Research symposium : Current options for circadian system assessment in cancer patients
Making Cancer a Priority at the European, national and regional level. ECPC Cancer Patient Summit